IgE antibodies to animal‐derived lipocalin, kallikrein and secretoglobin are markers of bronchial inflammation in severe childhood asthma
- 17 February 2012
- Vol. 67 (5), 661-669
- https://doi.org/10.1111/j.1398-9995.2012.02797.x
Abstract
Component-resolved allergy diagnostics enables the detection of crossreactive or species-specific allergen components. This study analysed Immunoglobulin E (IgE) profiles to single allergen components in relation to bronchial inflammation in severe childhood asthma. Ninety-five schoolchildren were assessed, 39 with controlled mild-to-moderate asthma and 56 uncontrolled severe asthmatics. Allergen components (n = 111) of food allergens, pollen and perennial aeroallergens were analysed using an immunosolid-phase allergen chip. Blood eosinophils (10(9) × l(-1)), bronchial inflammation (FeNO, ppb), lung function (FEV(1)%) and bronchial hyper-responsiveness (BHR) (dose-response slope of methacholine challenge) were measured. A specific IgE response to more than three animal-derived components--lipocalin (nMus m 1, rEqu c 1, Fel d 4, rCan f 1, 2), kallikrein (rCan f 5) and secretoglobin (rFel d 1)--was more common among severe asthmatics compared to children with controlled asthma (n = 14 vs n = 3, P = 0.030). These subjects also displayed higher blood eosinophils (0.65 vs 0.39, P = 0.021), higher Fractional exhaled nitric oxide (38 ppb vs 25 ppb, P = 0.021) and increased BHR (112 vs 28, P = 0.002) compared to other severe asthmatics positive to fewer lipocalin/kallikrein/secretoglobin components. Among all sensitized subjects, there were correlations between specific IgE levels for rFel d 4 and nMus m 1 (r = 0.751, P ≤ 0.001) and for rFel d 4 and rEqu c 1 (r = 0.850, P ≤ 0.001). Multi-sensitization towards lipocalin, kallikrein and secretoglobin components is associated with increased bronchial inflammation in severe asthmatics. In addition, crossreactive patterns were observed between different lipocalin components.Keywords
This publication has 33 references indexed in Scilit:
- The ImmunoCAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptomsClinical Biochemistry, 2011
- The clinical benefit of evaluating health‐related quality‐of‐life in children with problematic severe asthmaActa Paediatrica, 2011
- The complexities of defining atopy in severe childhood asthmaClinical & Experimental Allergy, 2011
- Problematic severe asthma: A proposed approach to identifying children who are severely resistant to therapyPediatric Allergy and Immunology, 2010
- Management of severe asthma in childrenThe Lancet, 2010
- Problematic severe asthma in children, not one problem but many: a GA2LEN initiativeEuropean Respiratory Journal, 2010
- Predictors of remitting, periodic, and persistent childhood asthmaJournal of Allergy and Clinical Immunology, 2010
- Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthmaJournal of Allergy and Clinical Immunology, 2007
- Features of severe asthma in school-age children: Atopy and increased exhaled nitric oxideJournal of Allergy and Clinical Immunology, 2006
- The recombinant allergen‐based concept of component‐resolved diagnostics and immunotherapy (CRD and CRIT)Clinical & Experimental Allergy, 1999